Semaglutide vs. Tirzepatide: Which Weight Loss Medication is Right for You?

If you're struggling to manage your weight, you've likely heard about newer medical weight loss treatments. 

At North Tex MedCare Clinic and Urgent Care, we understand that finding the right path can feel overwhelming with so many options available. Led by Frank Lee, MD, our team helps patients navigate these advanced treatments. We proudly serve our communities with convenient locations in Allen, Addison, Fort Worth, and San Antonio, Texas.

Deciding on semaglutide and tirzepatide depends on your unique health profile, medical history, and personal goals. Both are once-weekly injectable medications that can support significant weight loss in eligible adults, but they work in somewhat different ways. Here's how they compare so you can make an informed choice. 

Semaglutide vs. tirzepatide: How they compare in weight loss

When comparing semaglutide and tirzepatide, clinical evidence shows that tirzepatide generally leads to greater average weight loss. Tirzepatide acts on both GIP and GLP-1 receptors, while semaglutide acts on GLP-1 receptors.

In a 2025 head-to-head clinical trial of adults with obesity but without type 2 diabetes, participants taking tirzepatide lost an average of 20.2% of their body weight over 72 weeks, compared with 13.7% for those taking semaglutide.

Additionally, a 2024 real-world study found that people taking tirzepatide were more likely to achieve at least 15% weight loss than those taking semaglutide. Although average weight loss was greater with tirzepatide in these studies, individual results vary, and either medication may be appropriate depending on your health history and treatment goals.

What are the key differences in how they work?

The main difference between these medications lies in their active ingredients and how they interact with your body's hormone receptors. Semaglutide activates GLP-1 receptors involved in appetite regulation, while tirzepatide activates both GLP-1 and GIP receptors.

Semaglutide helps you feel full longer by delaying how quickly your stomach empties. Tirzepatide's dual action helps regulate appetite and calorie intake and also affects glucose-dependent insulin and glucagon secretion. 

Weight loss with GLP-1-based therapy can include some loss of lean mass as well as body fat. A 2025 joint clinical advisory from The Obesity Society and three other medical and nutrition organizations recommends adequate protein intake and strength training to help preserve lean mass.

Which medication is the right choice for you?

The right medication for you depends on your health history, budget, and specific wellness goals. 

Although tirzepatide has produced greater average weight loss in head-to-head research, semaglutide also has established cardiovascular outcomes data. Wegovy® is FDA-approved to reduce the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and overweight or obesity.

During your free weight loss consultation, we review your medical history to determine which option best fits your body. We'll also help you explore insurance and self-pay options for GLP-1 medications when medically appropriate.

Long-term weight management often involves medical guidance, personalized planning, and ongoing lifestyle support. At North Tex MedCare Clinic and Urgent Care, we're here to help you every step of the way, from your initial dose titration to long-term maintenance. If you're ready to take control of your health, schedule a visit with our experienced team today.